MAPK7 and atherosclerosis: In LDLR−/− mice (a genetically modified mouse model that is deficient in the LDL receptor gene and is commonly used in atherosclerosis research), the elimination of the ERK5 gene intensifies atherosclerosis and inhibits the expression of proteins associated with efferocytosis.